US Patent Issued to Eyedea Bio on Oct. 7 for "Intravitreal corticosteroid extended release implant and methods of use" (North Carolina Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,900, issued on Oct. 7, was assigned to Eyedea Bio LLC (Chapel Hill, N.C.).

"Intravitreal corticosteroid extended release implant and methods of use" was invented by Andres Garcia (Chapel Hill, N.C.) and Xunpei Liu (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Corticosteroid compositions including a corticosteroid drug substance (e.g., fluocinolone, fluocinolone acetonide, dexamethasone, dexamethasone phosphate, dexamethasone sodium phosphate, triamcinolone, and triamcinolone acetonide) or a or a salt or derivative thereof and one or more irregular-shaped particulate fatty acid or keto-enol tautomer complexation agents admixed in a...